Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerToolsCoverage CriteriaPrime_therapeutics

    Prime_therapeutics Coverage Criteria

    • Prime_therapeutics prior authorization
    • All Prime_therapeutics policy updates

    Latest Prime_therapeutics coverage criteria updates25

    • Coverage CriteriaClinical/Medical PolicyEff. 2026-11-01Resmetirom Prior Authorization and Quantity LimitsThis policy governs coverage of Rezdiffra (resmetirom) tablets for Boeing commercial members, including initial authorization, renewal, and quantity-limit exceptions. Coverage requires clinical criteria for noncirrhotic NASH/MASH with moderate-to-advanced fibrosis or another FDA-labeled indication, along with applicable safety, specialist, and documentation requirements.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-10-19PCSK9 Inhibitors Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization and quantity-limit approval for Praluent, Repatha formulations, Lerochol, and Lipfendra for commercial plan members. It establishes covered indications, statin-use or intolerance requirements, preferred-agent rules, continuation criteria, and quantity-limit exceptions.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-09-15Proton Pump Inhibitors (PPIs) Quantity Limit Program SummaryThis policy governs quantity limits and exception approval criteria for selected proton pump inhibitors and related agents on the Boeing commercial formulary. It applies to requests for quantities exceeding the program limit, including requests supported by specified diagnoses or dosing circumstances.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-09-15Tarpeyo Prior Authorization with Quantity Limit Program SummaryCommercial coverage of Tarpeyo (budesonide delayed-release 4 mg capsules) for patients with primary immunoglobulin A nephropathy at risk for disease progression, subject to clinical criteria, specialist involvement or consultation, contraindication screening, and quantity-limit requirements.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-09-15Tezspire Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization, renewal, and quantity-limit approval for Tezspire (tezepelumab-ekko) 210 mg/1.91 mL subcutaneous auto-injector for Boeing commercial members. Coverage requires diagnosis-specific clinical criteria, appropriate concurrent therapy, specialist involvement, and avoidance of prohibited concomitant immunomodulatory agents.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-07-01Acute Migraine Prior Authorization with Quantity Limit Program SummaryPrior authorization and quantity-limit review for selected acute migraine therapies for Boeing commercial members, including initial and renewal criteria, prerequisite therapy requirements, quantity-limit exceptions, and 12-month approval durations.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-07-01Alpha-1 Proteinase Inhibitors Prior Authorization Program SummaryThis policy governs prior authorization for alpha-1 proteinase inhibitor products for Boeing commercial members, including initial and renewal coverage criteria for alpha-1 antitrypsin deficiency and steroid-refractory acute graft-versus-host disease.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-07-01Continuous Glucose Monitor Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization and quantity limits for continuous glucose monitor receivers, sensors, and transmitters for commercial members. Coverage applies to specified Dexcom and FreeStyle Libre products when clinical criteria and applicable quantity-limit requirements are met.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-06-15Tavneos Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization and quantity-limit approval for Tavneos 10 mg capsules (avacopan) for Boeing commercial members. It establishes initial and renewal clinical criteria, quantity-limit exceptions, and a 12-month approval duration.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-05-01Krystexxa (pegloticase) Prior AuthorizationPrior authorization and medical-necessity criteria for Krystexxa (pegloticase) 8 mg/mL in adults with chronic gout who are refractory to conventional urate-lowering therapies and meet all stated clinical criteria.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-05-01Lysosomal Storage Disorders (LSD) Prior Authorization Program SummaryThis policy governs prior authorization and coverage criteria for enzyme-replacement therapies used to treat lysosomal storage disorders for Boeing commercial members, including requirements for initial and continuation therapy and non-preferred agents.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-04-01Brensocatib Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization and quantity-limit approval for Brinsupri (brensocatib) 10 mg and 25 mg tablets for Boeing commercial members. It establishes initial and renewal clinical criteria, quantity-limit exception criteria, and 12-month approval periods.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-03-15Ketorolac Quantity Limit Program SummaryThis policy governs quantity-limit coverage for 10 mg ketorolac tromethamine tablets under the Boeing commercial formulary. It establishes the standard dispensing limit and clinical criteria for approving quantities that exceed the limit.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-03-15Topiramate ER Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization and quantity limits for Trokendi XR and Qudexy XR extended-release topiramate capsules for Boeing commercial members. Coverage requires qualifying clinical criteria, absence of FDA-labeled contraindications, and compliance with the applicable 30-day quantity limit unless an approved exception applies.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-02-15CFTR Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization, renewal, and quantity-limit review for CFTR modulator drugs for Boeing commercial members. It applies to providers requesting Alyftrek, Kalydeco, Orkambi, Symdeko, or Trikafta.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-02-15Daybue Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization and quantity-limit approval for Daybue oral solution and Daybue stix oral powder packets for Boeing commercial members. Coverage is evaluated for patients with classic or typical Rett syndrome under the specified clinical and quantity-limit criteria.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2026-01-01Vasomotor Symptoms Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization and quantity-limit approval for Lynkuet (elinzanetant 60 mg) and Veozah (fezolinetant 45 mg) for vasomotor symptoms, including initial and renewal therapy. It applies to commercial plan members and requires clinical criteria and, when applicable, justification for quantities above the program limit.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2025-12-15Elagolix and Relugolix Prior Authorization with Quantity Limit Program SummaryThis commercial Boeing policy governs prior authorization and quantity limits for Orilissa, Oriahnn, and Myfembree. Coverage applies to eligible premenopausal patients receiving therapy for endometriosis-associated pain or heavy menstrual bleeding associated with uterine fibroids, subject to clinical criteria, contraindication review, duration limits, and product-specific quantity limits.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2025-12-15Procysbi Prior Authorization Program SummaryThis policy governs prior authorization for Procysbi for commercial members. Approval requires an eligible indication, applicable age support, prior Cystagon history or qualifying intolerance or contraindication, specialist involvement, and no FDA-labeled contraindication to Procysbi.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyEff. 2025-12-15Zilbrysq Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization and quantity-limit approval for Zilbrysq (zilucoplan) subcutaneous prefilled syringes for commercial plan members. It establishes initial and renewal clinical criteria, nonpreferred-agent requirements, prohibited combination therapy, contraindication screening, and dispensing limits.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyHarliku Prior Authorization with Quantity Limit Program SummaryThis policy governs coverage of Harliku 2 mg tablets for alkaptonuria under the Boeing commercial formulary, including prior authorization, prerequisite-agent, specialist, contraindication, renewal, and quantity-limit requirements.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyIL-5 Inhibitors Prior Authorization with Quantity Limit Program SummaryThis policy governs prior authorization, renewal, and quantity-limit approval for Fasenra (benralizumab) and Nucala (mepolizumab) for covered eosinophilic and related inflammatory conditions. It applies to Boeing commercial members and requires clinical documentation, condition-specific maintenance therapy, specialist involvement, and review of concomitant immunomodulator use.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyMyalept (metreleptin) Prior Authorization Program SummaryThis policy governs prior authorization for Myalept 11.3 mg subcutaneous injection for Boeing commercial plan members. Coverage requires a qualifying indication, clinical documentation, specialist involvement or consultation, absence of contraindications and limitations of use, and dosing within FDA labeling.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicySGLT Inhibitors Quantity Limit Program SummaryThis program summary governs quantity limits for selected SGLT inhibitor products and SGLT inhibitor combination products on the Boeing commercial formulary. It defines standard quantities and clinical criteria for approving quantities that exceed the program limit.All prime_therapeutics updates
    • Coverage CriteriaClinical/Medical PolicyViscosupplementation for Osteoarthritis Prior Authorization Program SummaryThis policy governs prior authorization for intra-articular viscosupplementation products used to treat knee osteoarthritis in commercial members. Coverage requires documented clinical criteria, failure of conservative therapies, appropriate treatment timing, absence of contraindications, and FDA-labeled dosing.All prime_therapeutics updates
    1–25 of 26
    1 / 2

    Tool Description

    Search Prime_therapeutics coverage criteria and medical necessity requirements across 21,000+ policies from 170+ payers.

    Search a drug (“Wegovy”), a procedure (“knee replacement”), or a policy name, then filter by payer, specialty, policy type, or effective year. Or start from the largest publishers: UnitedHealthcare coverage criteria and Cigna coverage criteria.

    Each result links the full policy page, which lists the clinical requirements, covered codes, and effective dates from the source document.

    Pair a criteria search with the prior authorization lookup for approval requirements, the timely filing lookup for claim deadlines, the live policy updates feed for the newest payer publications, and payer profiles for contacts and coverage context.

    FAQ

    Coverage criteria are the specific clinical requirements a payer sets for covering a drug, procedure, or service: diagnoses, symptom duration, prior treatments tried, age limits, and documentation. They are published inside medical policies and clinical criteria documents, and a claim or authorization that does not meet them is denied as not medically necessary.

    Tool Description

    Search Prime_therapeutics coverage criteria and medical necessity requirements across 21,000+ policies from 170+ payers.

    Search a drug (“Wegovy”), a procedure (“knee replacement”), or a policy name, then filter by payer, specialty, policy type, or effective year. Or start from the largest publishers: UnitedHealthcare coverage criteria and Cigna coverage criteria.

    Each result links the full policy page, which lists the clinical requirements, covered codes, and effective dates from the source document.

    Pair a criteria search with the prior authorization lookup for approval requirements, the timely filing lookup for claim deadlines, the live policy updates feed for the newest payer publications, and payer profiles for contacts and coverage context.

    FAQ

    Coverage criteria are the specific clinical requirements a payer sets for covering a drug, procedure, or service: diagnoses, symptom duration, prior treatments tried, age limits, and documentation. They are published inside medical policies and clinical criteria documents, and a claim or authorization that does not meet them is denied as not medically necessary.

    Coverage Criteria by Payer

    Advancedhealth12—
    Aetna2432021-12-01
    Agency For Health Care Administration1182026-07-01
    Alabama Medicaid92026-06-14
    Alacura_medical_transportation_management22025-12-15
    Alaska Medicaid312022-11-23
    Align_powered_by_sanford_health_plan12026-11-01
    Allcareadvantage612026-06-02
    Allcarehealthcco1—
    Alliance Health472025-01-01
    Alliance_health_nc62026-01-01
    Aloha Care272026-01-01
    Ambetter Georgia5002026-11-01
    Ambetter Nevada1722026-12-01
    American_specialty_health32025-12-15
    Amerigroup102026-04-01
    AmeriHealth42026-01-01
    AmeriHealth Caritas532026-08-01
    Amerihealth_caritas_vip_care672026-09-18
    Amerihealthcaritaslouisiana172023-08-01
    Anthem4052026-10-01
    Arizona Complete Health1342026-08-01
    Arizona Health Care Cost Containment System112022-04-01
    Arkansas_blue_cross_blue_shield62027-02-01
    Aspirus Arise202026-02-01
    Astivahealth12023-12-06
    Avalon_healthcare_solutions392026-12-01
    AvMed3822023-07-26
    Baylor Scott & White Health Plan772026-10-01
    Baylor_scott_and_white_health_plan32026-11-01
    Bcbsvermont212027-02-01
    Beacon-Health-Options42026-02-15
    Blue Cross Blue Shield - Alabama7—
    Blue Cross Blue Shield - Arizona7—
    Blue Cross Blue Shield - Illinois92026-09-04
    Blue Cross Blue Shield - Iowa5052026-10-25
    Blue Cross Blue Shield - Kansas352026-11-26
    Blue Cross Blue Shield - Louisiana872027-01-01
    Blue Cross Blue Shield - Maine772026-11-01
    Blue Cross Blue Shield - Massachusetts3282026-10-01
    Blue Cross Blue Shield - Michigan582026-06-20
    Blue Cross Blue Shield - Minnesota3—
    Blue Cross Blue Shield - Nebraska1792026-07-01
    Blue Cross Blue Shield - Nevada122024-01-01
    Blue Cross Blue Shield - New Mexico542026-09-04
    Blue Cross Blue Shield - North Carolina5282026-08-01
    Blue Cross Blue Shield - North Dakota402027-01-01
    Blue Cross Blue Shield - Oklahoma852026-04-24
    Blue Cross Blue Shield - Rhode Island5692027-02-01
    Blue Cross Blue Shield - South Carolina462026-10-01
    Blue Cross Blue Shield - South Dakota502026-09-30
    Blue Cross Blue Shield - Tennessee4392027-01-30
    Blue Cross Blue Shield - Texas282026-04-24
    Blue Cross Blue Shield - Wisconsin842026-07-01
    Blue Cross Blue Shield - Wyoming92026-01-01
    Blue KC172025-10-01
    Blue_care_network_of_michigan12019-03-01
    Blue_cross_complete_of_michigan52027-01-02
    Blue_shield_of_california1292026-11-01
    Bluecross Idaho1232027-01-01
    California Department Of Health Care Services2—
    Capital Bluecross2412026-07-01
    Care_continuum192025-12-18
    CareFirst162026-03-01
    Careoregon1002026-10-01
    CareSource2102030-12-25
    CareSource Georgia392026-12-01
    Caresourcegeorgia1102026-11-01
    Carolina_complete_health_inc12020-02-01
    Carolinabehavioralhealth24—
    Cdphp12027-01-01
    Cencalhealth52024-01-01
    Centene12762026-08-01
    Chocchildrenshospitalorangecountyhealthalliance72026-05-21
    Chp1—
    Cigna16052026-12-15
    Clearhealthalliance112020-01-01
    Clover_health108—
    Colorado Division Of Insurance12022-01-01
    Colorado Rocky Mountain Health Plans10542026-11-15
    Coloradoaccess12024-06-05
    Community Health Plan Washington862026-01-01
    Community-Care802024-04-01
    Communitycareindependentpracticeassociation8—
    Communityhealthchoice172025-11-01
    ConnectiCare932026-09-15
    Countycare182026-09-01
    Curative65—
    Cvs_caremark9—
    Delaware Department Of Health And Social Services12017-06-02
    Delaware First Health332026-02-01
    Deltadentalofohio232025-06-21
    Dentaquestdental22020-09-01
    Denver-Health-Medical-Plan3—
    Devoted_health232026-11-09
    DHA1642026-02-24
    District Of Columbia Department Of Health Care Finance1—
    Elderplan32021-08-01
    EmblemHealth3712026-05-08
    Empire Bluecross272026-10-27
    Eocco3692026-07-09
    Eternalhealth12026-11-01
    Evicore472026-09-01
    Evolent2—
    Excellus_health_plan_inc172026-10-15
    Executive Office Of Health And Human Services332023-07-01
    Fallon Health32026-12-01
    Fallon_community_health_plan_inc862027-01-01
    Fidelis Care1562025-10-01
    Florida Blue92026-01-01
    Geisinger Health Plan152026-09-15
    Georgia Department Of Community Health46—
    Globalhealth42026-08-01
    Goldcoasthealthplan872026-09-03
    Hap_caresource_mi_coordinated_health1222026-09-01
    Harvard Pilgrim Health Care662026-08-11
    Hawaii Department Of Human Services92025-12-08
    Hawaii Medical Service Association (HMSA)1612026-07-01
    Health Alliance Plan (HAP)62026-01-01
    Health Care Access Bureau And Bureau Of Managed Care, Division Of Insurance22022-11-08
    Health Net4822026-08-01
    Health_choice_arizona1002026-12-01
    Health-New-England682027-02-01
    Healthchoiceofoklahoma1—
    Healthfirst152026-11-01
    Healthfirstofnewyork22025-07-01
    Healthnetnational5—
    HealthPartners272026-06-01
    Healthplanofupperohiovalley122026-02-02
    Healthspring212026-09-15
    Healthybluelouisiana4—
    Healthymissisippi1—
    Hennepinhealth22023-09-01
    Highmark Blue Cross Blue Shield Wny82026-08-01
    Highmark Blueshield Neny472024-01-01
    Highmark Delaware42021-11-22
    Highmark Pennsylvania62016-09-26
    Highmark West Virginia4—
    Hometownhealthproviders12026-01-01
    Humana42023-07-01
    Husky_health802026-11-01
    Independence_administrators1—
    Independence_blue_cross1—
    Independent Health532026-06-01
    Indiana Department Of Insurance9—
    Integrated_home_care_services2—
    Iowa Department Of Health And Human Services62025-01-01
    Johns_hopkins_health_plans92026-07-01
    Kaiser Permanente1602026-12-01
    Kansas Department Of Health And Environment122025-07-10
    Kernfamilyhealthcare72020-10-06
    Longevityhealthplanofcolorado102025-12-12
    Louisiana Department Of Health62025-10-01
    Lucet122025-02-01
    Magellan_healthcare2—
    Maryland Medicaid (Maryland Department Of Health)1—
    Marylandphysicianscarempc72024-01-01
    Mass General Brigham Health Plan3372027-01-04
    Massachusetts Executive Office Of Health And Human Services332025-06-25
    Masshealth1—
    Mclaren Health Plan12024-05-21
    Medica1—
    Medical Mutual - Ohio2142026-06-01
    Medicare12026-01-01
    Medimpact342026-06-01
    Mediviewcurative822026-11-13
    Medstarfamilychoicedistrictofcolumbia102026-07-01
    Medstarfamilychoicemaryland72026-07-01
    Memorialcareselecthealthplan1—
    Meridian2322026-09-01
    Meridian_health_plan_of_michigan92026-08-01
    Messa1—
    Metroplushealth12018-10-26
    Mhn8732026-08-01
    Mississippi Division Of Medicaid1152026-07-01
    Missouri Department Of Social Services3—
    Moda Health932026-11-01
    Moda_health_plan_inc252026-08-13
    Molina Healthcare6802027-01-01
    Montana Department Of Public Health & Human Services182025-10-01
    Mutualofomaha62026-11-01
    MVP Health Care172026-10-01
    Neighborhood Health Plan Of Rhode Island25712026-11-01
    Network_health2—
    New Hampshire Department Of Health And Human Services10—
    New Mexico Health Care Authority332025-04-01
    New York State Department Of Health22026-07-01
    North Carolina Medicaid212024-03-01
    North Dakota Department Of Health & Human Services82007-03-01
    North Dakota Insurance Department1—
    Northwood1222025-12-11
    Ohio Department Of Medicaid1—
    Oklahoma Health Care Authority402026-06-15
    Optum592026-11-01
    Optum_behavioral_health8—
    Oregon Health Authority12025-11-01
    Orthonet102026-06-04
    Oscar Health1142027-01-01
    Pacificsource32012-04-29
    Pacificsourcecommunitysolutions62025-11-01
    Parklandcommunityhealthplan62026-10-16
    Partners_health_management492025-08-01
    Partners_insurance_company_dba_jefferson_health_plans212026-12-07
    Peach State Health Plan522025-08-01
    Pennsylvania Department Of Human Services12018-01-08
    Pennsylvania Insurance Department82024-01-08
    Phccalifornia132025-08-14
    Premera Bluecross9882026-10-14
    Premerabluecrossofwashington432027-02-05
    Presbyterian Health Plan162026-11-01
    Prime_therapeutics262026-11-01
    Priority Health1342026-08-01
    Priority_health_medicare202026-09-01
    Providence Health Plan1602026-11-01
    QualChoice1442026-09-01
    Quartz42024-07-01
    Regence912026-12-01
    Sanford Health Plan1—
    Sanfranciscohealthplan112025-11-20
    Scrippshealthplan12024-08-01
    Security_health_plan_of_wisconsin_inc652026-08-01
    Select_health542026-07-01
    SelectHealth432026-01-01
    Sierra Health And Life2412026-08-01
    Simplyhealthcare42025-12-02
    South Carolina Department Of Health And Human Services1—
    South Dakota Department Of Social Services1—
    Summacare212026-10-08
    Tdsfidelis1—
    Tennessee Department Of Finance And Administration — Division Of TennCare1—
    Texaschildrenshealthplan42024-03-22
    Trillium_health_resources2—
    UCare172024-04-01
    Ultimatehealthplan22025-09-09
    Umwahealthretirementfunds5—
    UnitedHealthcare20862026-11-15
    Univerahealthcare1702027-01-01
    University Health Alliance (HSA)342026-10-01
    Universityoftexasmedicalboard42026-08-27
    Universityofutahhealthplans152026-10-26
    UPMC Health Plan173—
    Utah Medicaid12022-10-01
    Venturacountyhealthcareplan3432026-01-15
    Vermont Agency Of Human Services – Department Of Vermont Health Access112026-01-01
    Viva Health2872026-07-01
    Vivahealthplan34—
    Vns_health1—
    Washington Office Of The Insurance Commissioner42024-12-10
    Washington State Health Care Authority222026-08-01
    WellCare532026-07-01
    Wellcare Hawaii82026-02-01
    Wellfleet52025-11-01
    Wellpoint412025-06-11
    West Virginia Bureau For Medical Services (Department Of Human Services)662026-03-01
    Westernhealthadvantage1—
    WPS Health Insurance212026-10-01
    Zing_health32026-01-01

    Go deeper

    Explore OpenPayer Data

    Coverage policies are updated every day. Follow payer coverage policy updates in the live policy feed, or browse all CPT, HCPCS and DRG billing codes.

    Toolbox

    More OpenPayer Tools

    • Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
    • Billing Code Reimbursement RatesBuild a reimbursement rate report across any mix of billing codes and states, comparing commercial payers against Medicare.
    • Payer Comparison DashboardPick 2-5 payers to compare market share, premium, and membership by region, all at once.
    • Facility Comparison DashboardPick 2-6 hospital facility types (or add a specific hospital) to compare facility count, revenue, net income, and Medicare/Medicaid payer mix by region, all at once.
    • Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
    • Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
    • Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
    • CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
    • Prior Authorization LookupSearch payer prior authorization policies by drug, procedure, or policy name.
    • Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
    • Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.